<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Public Health</journal-id><journal-id journal-id-type="iso-abbrev">Front Public Health</journal-id><journal-id journal-id-type="publisher-id">Front. Public Health</journal-id><journal-title-group><journal-title>Frontiers in Public Health</journal-title></journal-title-group><issn pub-type="epub">2296-2565</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29707533</article-id><article-id pub-id-type="pmc">5906532</article-id><article-id pub-id-type="doi">10.3389/fpubh.2018.00105</article-id><article-categories><subj-group subj-group-type="heading"><subject>Public Health</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Persuasiveness of Statistics and Patients&#x02019; and Mothers&#x02019; Narratives in Human Papillomavirus Vaccine Recommendation Messages: A Randomized Controlled Study in Japan</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Okuhara</surname><given-names>Tsuyoshi</given-names></name><xref ref-type="corresp" rid="fn001">*</xref><uri xlink:type="simple" xlink:href="https://frontiersin.org/people/u/462880"/></contrib><contrib contrib-type="author"><name><surname>Ishikawa</surname><given-names>Hirono</given-names></name><uri xlink:type="simple" xlink:href="https://frontiersin.org/people/u/351791"/></contrib><contrib contrib-type="author"><name><surname>Okada</surname><given-names>Masafumi</given-names></name><uri xlink:type="simple" xlink:href="https://frontiersin.org/people/u/542275"/></contrib><contrib contrib-type="author"><name><surname>Kato</surname><given-names>Mio</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kiuchi</surname><given-names>Takahiro</given-names></name></contrib></contrib-group><aff><institution>Department of Health Communication, School of Public Health, The University of Tokyo</institution>, <addr-line>Tokyo</addr-line>, <country>Japan</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Michal Grivna, United Arab Emirates University, United Arab Emirates</p></fn><fn fn-type="edited-by"><p>Reviewed by: Lili Ding, Cincinnati Children&#x02019;s Hospital Medical Center, United States; Apostolos Zaravinos, European University Cyprus, Cyprus</p></fn><corresp id="fn001">*Correspondence: Tsuyoshi Okuhara, <email>okuhara-ctr@umin.ac.jp</email></corresp><fn fn-type="other" id="fn002"><p>Specialty section: This article was submitted to Public Health Education and Promotion, a section of the journal Frontiers in Public Health</p></fn></author-notes><pub-date pub-type="epub"><day>12</day><month>4</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>6</volume><elocation-id>105</elocation-id><history><date date-type="received"><day>06</day><month>2</month><year>2018</year></date><date date-type="accepted"><day>27</day><month>3</month><year>2018</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2018 Okuhara, Ishikawa, Okada, Kato and Kiuchi.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Okuhara, Ishikawa, Okada, Kato and Kiuchi</copyright-holder><license xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract abstract-type="executive-summary"><sec id="ST1"><title>Background</title><p>The human papillomavirus (HPV) vaccination percentage among age-eligible girls in Japan is only in the single digits. This signals the need for effective vaccine communication tactics. This study aimed to examine the influence of statistical data and narrative HPV vaccination recommendation massages on recipients&#x02019; vaccination intentions.</p></sec><sec id="ST2"><title>Methods</title><p>This randomized controlled study covered 1,432 mothers who had daughters aged 12&#x02013;16&#x02009;years. It compared message persuasiveness among four conditions: statistical messages only; narrative messages of a patient who experienced cervical cancer, in addition to statistical messages; narrative messages of a mother whose daughter experienced cervical cancer, in addition to statistical messages; and a control. Vaccination intentions to have one&#x02019;s daughter(s) receive the HPV vaccine before and after reading intervention materials were assessed. Statistical analysis was conducted using analysis of variance with Tukey&#x02019;s test or Games&#x02013;Howell <italic>post hoc</italic> test, and analysis of covariance with Bonferroni correction.</p></sec><sec id="ST3"><title>Results</title><p>Vaccination intentions after intervention in the three intervention conditions were higher than the control condition (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001). A mother&#x02019;s narrative messages in addition to statistical messages increased HPV vaccination intention the most of all tested intervention conditions. A significant difference in the estimated means of intention with the covariate adjustment for baseline value (i.e., intention before intervention) was found between a mother&#x02019;s narrative messages in addition to statistical messages and statistical messages only (<italic>p</italic>&#x02009;=&#x02009;0.040).</p></sec><sec id="ST4"><title>Discussion</title><p>Mothers&#x02019; narrative messages may be persuasive when targeting mothers for promoting HPV vaccination. This may be because mothers can easily relate to and identify with communications from other mothers. However, for effective HPV vaccine communication, further studies are needed to understand more about persuasive differences in terms of statistics, narratives, and narrators. Directions for future research are also suggested.</p></sec></abstract><kwd-group><kwd>human papillomavirus vaccination</kwd><kwd>anti-vaccination movement</kwd><kwd>narrative</kwd><kwd>persuasion</kwd><kwd>health communication</kwd></kwd-group><counts><fig-count count="1"/><table-count count="3"/><equation-count count="0"/><ref-count count="53"/><page-count count="9"/><word-count count="6766"/></counts></article-meta></front><body><sec sec-type="introduction" id="S1"><title>Introduction</title><p>In communicating about risks and benefits of public health practices, it is essential to convey evidence-based information and to influence the audience to make better health decisions (<xref rid="B1" ref-type="bibr">1</xref>). This concept of public health communication is especially important in the current human papillomavirus (HPV) vaccination crisis in Japan. The HPV vaccination rate for age-eligible girls in Japan was as high as 70&#x02013;80% in 2011 and 2012 (<xref rid="B2" ref-type="bibr">2</xref>). However, owing to a series of negative campaigns by mass media on severe adverse reactions allegedly caused by HPV vaccination, such as difficulties walking and memory impairment, the proactive recommendation of HPV vaccination was suspended by the Ministry of Health, Labor, and Welfare in June 2013. As a direct result, the HPV vaccination rate among age-eligible girls fell sharply to only a few percent by 2014 (<xref rid="B2" ref-type="bibr">2</xref>). Fears concerning adverse reactions to HPV vaccination are now a significant reason for avoiding vaccination in Japan and other countries (<xref rid="B3" ref-type="bibr">3</xref>&#x02013;<xref rid="B7" ref-type="bibr">7</xref>), despite studies demonstrating the safety of HPV vaccines (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B9" ref-type="bibr">9</xref>). In this critical situation, conveying scientific information alone may not sway the biased anti-HPV vaccination sentiment; influential and persuasive communication tactics to encourage the audience to make less biased decisions are needed.</p><p>In Japan, unlike in many other developed countries, the primary care doctor system is underdeveloped, and school-administrated HPV vaccination has not been routinely performed. Most mothers and their daughters do not have health professionals whom they can consult with about HPV vaccines. They gather information independently and judge by themselves whether or not vaccination will be sought. Accordingly, when proactive recommendation of HPV vaccination resumes in the future, publicizing online and offline vaccination recommendation messages from the Ministry of Health, Labor, and Welfare and municipalities will be a means for recommending vaccination to mothers and their daughters. Therefore, examining persuasive messages that recommend HPV vaccination is an urgent issue in Japan.</p><p>Since Aristotle, the use of evidence has been a primary means of enhancing message persuasiveness. Evidence is the set of factual statements that originate from a source other than the communicator and are offered to verify the communicator&#x02019;s claims (<xref rid="B10" ref-type="bibr">10</xref>). Evidence can be divided broadly into two categories: statistical and narrative evidence (<xref rid="B11" ref-type="bibr">11</xref>). Statistical evidence, such as frequencies and percentages, provide proof in the form of summary information across a larger number of cases (<xref rid="B11" ref-type="bibr">11</xref>); e.g., &#x0201c;The frequency of severe adverse reactions to the HPV vaccine, such as acute disseminated encephalomyelitis, is one in 4.3 million.&#x0201d; Narrative evidence refers to the use of case stories or examples to support the argument offered by the communicator (<xref rid="B11" ref-type="bibr">11</xref>); e.g., &#x0201c;I am suffering from the aftereffect of cervical cancer. Therefore, I recommend you receive the HPV vaccine to prevent cervical cancer.&#x0201d; Studies indicate that presenting statistical or narrative evidence almost always enhances message persuasiveness (<xref rid="B10" ref-type="bibr">10</xref>&#x02013;<xref rid="B12" ref-type="bibr">12</xref>).</p><p>A primary question among scholars has focused on the relative persuasiveness of messages presenting statistical evidence compared with those presenting narrative evidence. At present, study results are somewhat contradictory, and no definitive difference has been demonstrated between narrative and statistical evidence (<xref rid="B10" ref-type="bibr">10</xref>&#x02013;<xref rid="B14" ref-type="bibr">14</xref>). However, using narratives to motivate health behavior is an emerging form of persuasion in public health (<xref rid="B15" ref-type="bibr">15</xref>&#x02013;<xref rid="B17" ref-type="bibr">17</xref>). Several recent studies in the context of vaccine communication show that narrative messages about experiences of disease increase the audience&#x02019;s risk perception of developing the disease, vaccination intention, and behaviors to prevent the disease to a greater degree than do didactic messages (<xref rid="B18" ref-type="bibr">18</xref>&#x02013;<xref rid="B21" ref-type="bibr">21</xref>). Accordingly, use of narrative messages in addition to evidence-based statistical messages to counter the influence of anti-vaccination narratives of alleged victims of vaccine adverse reactions has been proposed (<xref rid="B22" ref-type="bibr">22</xref>&#x02013;<xref rid="B25" ref-type="bibr">25</xref>). Thus, our first research question emerges herein: <italic>will a narrative message in addition to statistical messages result in higher intention to receive the HPV vaccine than statistical messages only?</italic></p><p>Several models have been proposed to explain the persuasiveness of narratives, including the transportation-imagery model (<xref rid="B26" ref-type="bibr">26</xref>), extended elaboration likelihood model (<xref rid="B27" ref-type="bibr">27</xref>), and entertainment overcoming resistance model (<xref rid="B28" ref-type="bibr">28</xref>). These models share the audience&#x02019;s identification with a character of a narrative and transportation (i.e., caught up in, or carried away by, the story) as factors that serve to enhance the persuasiveness of narratives. Among various factors that have been explored, identification and transportation are the primary factors presently warranted by the literature (<xref rid="B29" ref-type="bibr">29</xref>).</p><p>Although the relationship of the influence of identification and transportation on narrative persuasion is not entirely clear, identification may foster transportation and consequently enhance persuasiveness (<xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B31" ref-type="bibr">31</xref>). Identification is a mechanism through which audience members experience reception and interpretation of the text internally, as if the events were happening to them (<xref rid="B32" ref-type="bibr">32</xref>). During identification, the audience imagines that he or she becomes the character and replaces his or her personal identity and role as an audience member with the identity and role of the character (<xref rid="B32" ref-type="bibr">32</xref>). A number of studies show that greater identification with characters is associated with greater persuasiveness of narratives (<xref rid="B33" ref-type="bibr">33</xref>&#x02013;<xref rid="B40" ref-type="bibr">40</xref>). A meta-analysis reported that perceived identification produced statistically significant effects on forming of story-consistent attitudes, beliefs, and behaviors on recipients (<xref rid="B41" ref-type="bibr">41</xref>). In addition, in the context of HPV vaccine communication, a study showed that the first-person narrative of a college student resulted in higher perceived risk of HPV infection than a report in the third-person narrative among participants who were college students (<xref rid="B20" ref-type="bibr">20</xref>). The authors discussed that the first-person narrative of a peer was easier to identify with for participants (<xref rid="B20" ref-type="bibr">20</xref>). Another study of college students found more HPV vaccine inoculation behaviors in the group who viewed the narrative of a college student than the narrative of a medical expert (<xref rid="B21" ref-type="bibr">21</xref>). Similarly, it was thought that participants could more easily identify with the narrative of a peer.</p><p>Japanese refer to the HPV vaccine as &#x0201c;sikyu keigan wakuchin&#x0201d; (i.e., cervical cancer vaccine). Therefore, a narrative of a cervical cancer patient who recommends HPV vaccination may be persuasive for some audiences. However, healthy individuals may have difficulty identifying with a patient. When targeting mothers to promote HPV vaccination, the narrative of a mother who has a daughter may be easier to identify with and more persuasive than the narrative of a patient. Thus, our second research question emerges herein: <italic>will the narrative of a mother whose daughter experienced cervical cancer result in higher intention to have their daughters receive the HPV vaccine than the narrative of a patient who experienced cervical cancer among participants who are mothers with daughters?</italic></p><p>This study aimed to examine the influence of HPV vaccination recommendation messages. It did so by using statistical data and narratives on vaccination intention of mothers with daughters aged 12&#x02013;16&#x02009;years, in Japan. This will help ensure that persuasive vaccine recommendation messages will be disseminated when proactive recommendation of the vaccination eventually resumes. A randomized controlled study was conducted to answer the above two research questions.</p></sec><sec sec-type="materials|methods" id="S2"><title>Materials and Methods</title><sec id="S2-1"><title>Study Design and Participants</title><p>Participants were recruited from persons registered in a survey company database in Japan. Eligibility criteria were mothers who have a daughter(s) aged 12&#x02013;16&#x02009;years who has never received HPV vaccination. An e-mail was sent to registered persons, which described that questionnaires (and materials) were created and intended for research purposes only. Recipients who were eligible and consented to participate in the study were invited to a web-based survey. After conducting a pretest among 120 participants in August 2017, a total of 1,432 mothers excluding pretest participants completed the survey in September 2017.</p><p>When participants consented to participate in the study on the web screen, they were randomly assigned to a group that received statistical messages only, a group that received a patient&#x02019;s narrative messages in addition to statistical messages, a group that received a mother&#x02019;s narrative messages in addition to statistical messages, or a control group by algorithm included in the web-based survey computer program. Because required sample size in each intervention group was 394 participants (this will be discussed later), recruiting stopped when the number of participants of all of the intervention groups reached 394. All participants were asked about items such as sociodemographic information, history of cancer, and sexually transmitted disease, and whether they knew about the media coverage of adverse reactions to the HPV vaccine. Participants in the intervention groups were asked their intention to have their daughter(s) receive the HPV vaccine before and after reading the intervention material. They were also asked their attitude toward HPV vaccination after reading the material. Participants in the control group were asked their intention of vaccination without reading intervention materials. Token gifts were given to all participants upon completion of the study by the survey company. The protocol was approved by the ethical review committee at the Graduate School of Medicine, The University of Tokyo. All subjects gave written informed consent in accordance with the Declaration of Helsinki.</p></sec><sec id="S2-2"><title>Intervention Materials</title><p>Statistical content on the materials of the three intervention groups was taken from the websites of the Ministry of Health, Labor, and Welfare; National Cancer Center Japan; and a consensus statement from 17 relevant Japanese academic societies on the promotion of the HPV vaccine (<xref rid="B9" ref-type="bibr">9</xref>). The statistical content included cervical cancer morbidity and mortality and HPV vaccine efficacy and safety. The content was identical among the three intervention materials. The statistical message contained a total of 745 Japanese characters.</p><p>Narrative contents of a patient and a mother were taken from a website of the United States Centers for Disease Control and Prevention (<xref rid="B42" ref-type="bibr">42</xref>) and modified for this study. In the narrative content, the narrator told the experience of being diagnosed with cervical cancer, having a total hysterectomy, giving up the dream of having children, suffering from complications, fearing cancer recurrence, and recommending HPV vaccination. These narrative contents were identical between the two intervention materials (patient&#x02019;s and mother&#x02019;s narratives) except for the subject of the narrative (i.e., &#x0201c;I,&#x0201d; in the patient&#x02019;s narrative and &#x0201c;my daughter&#x0201d; in the mother&#x02019;s narrative). The patient&#x02019;s and mother&#x02019;s narratives contained a total number of 341 and 357 Japanese characters, respectively. Appendix S1 in Supplementary Material shows the statistical messages and mother&#x02019;s narrative used in this study, which was translated into English for this report.</p></sec><sec id="S2-3"><title>Outcome Measures</title><p>The primary outcome was intention to have one&#x02019;s daughter(s) receive the HPV vaccine after intervention. Intention before intervention was assessed for covariate adjustment for baseline value and changes in intention before and after intervention. Participants responded to the following three questions on 1&#x02013;6 scales ranged from &#x0201c;extremely unlikely,&#x0201d; &#x0201c;unlikely,&#x0201d; &#x0201c;a little unlikely,&#x0201d; &#x0201c;a little likely,&#x0201d; &#x0201c;likely,&#x0201d; to &#x0201c;extremely likely&#x0201d;: (1) &#x0201c;How likely would you have your daughter(s) receive the HPV vaccine sometime soon?&#x0201d;; (2) &#x0201c;If you were faced with the decision of whether to have your daughter(s) receive the HPV vaccine today, how likely is it that you would choose to have her receive the vaccine?&#x0201d;; and (3) &#x0201c;How likely would you have your daughter(s) receive the HPV vaccine in the future?&#x0201d; A summary score calculated by dividing the sum of scores of the three questions by three (i.e., mean) was used in the analysis. Higher scores indicate greater intentions. This measure was adapted from a previous study (<xref rid="B43" ref-type="bibr">43</xref>). The secondary outcome was attitude toward HPV vaccination. Participants rated &#x0201c;having my daughter(s) receive the HPV vaccine&#x0201d; on a scale consisting of five 1&#x02013;6 semantic differential items (bad/good, harmful/beneficial, foolish/wise, threatening/assuring, and risky/safe). A summary score calculated by dividing the sum of scores of the five items by five (i.e., mean) was used in the analysis. Higher scores indicate more favorable attitudes. This measure was adapted from a previous study (<xref rid="B44" ref-type="bibr">44</xref>).</p></sec><sec id="S2-4"><title>Sample Size</title><p>A previous study of HPV vaccination communication showed that the effect sizes for comparing vaccination intention between &#x0201c;statistics only&#x0201d; and &#x0201c;a narrative in addition to statistics&#x0201d; conditions and between a peer&#x02019;s and a third-person&#x02019;s narrative conditions were small (Cohen&#x02019;s <italic>d</italic>&#x02009;=&#x02009;0.2) (<xref rid="B20" ref-type="bibr">20</xref>). Based on these results, we conducted a power analysis using the G*Power 3 program (<xref rid="B45" ref-type="bibr">45</xref>, <xref rid="B46" ref-type="bibr">46</xref>) to determine sample size. This analysis showed that 394 participants were required in each of the three intervention groups to detect an effect size (Cohen&#x02019;s <italic>d</italic>) of 0.2 for comparing vaccination intention between &#x0201c;statistics only&#x0201d; and &#x0201c;a narrative in addition to statistics&#x0201d; conditions and between patient&#x02019;s and mother&#x02019;s narrative conditions at an alpha error rate of 0.05 (two-tailed) and a beta error rate of 0.20. We set the sample size at about 200 for the control group because the number of participants who matched the eligibility criteria was limited among persons registered with the survey company.</p></sec><sec id="S2-5"><title>Statistical Analysis</title><p>Descriptive statistics were used to describe participants&#x02019; sociodemographic information, history, and baseline intention to vaccinate, by summarizing in percentages for categorical variables and as mean&#x02009;&#x000b1;&#x02009;SD for continuous variables. Analysis of variance (ANOVA) was conducted with the intention of vaccination or attitude toward vaccination as the dependent variable and the group assignment as the independent variable. Tukey&#x02019;s test was conducted on significant main effects where appropriate. The Games&#x02013;Howell <italic>post hoc</italic> test was performed when the assumption of homogeneity of variances was not satisfied. According to recommendations in the literature including the Consolidated Standards of Reporting Trials statement, significance testing of baseline differences and covariate adjustment for variables that differ at baseline are not recommended because such adjustment is likely to bias the estimated intervention effect. However, covariate adjustment for a baseline value of a quantitative outcome is recommended because a strong correlation between the baseline value and the outcome is expected (<xref rid="B47" ref-type="bibr">47</xref>&#x02013;<xref rid="B50" ref-type="bibr">50</xref>). Therefore, we conducted an analysis of covariance (ANCOVA) with the baseline intention (i.e., before reading the intervention materials) as the covariate. Bonferroni correction was applied for the <italic>post hoc</italic> test to compare adjusted means of intentions. In addition, intention of vaccination was compared between before and after intervention using the paired <italic>t</italic>-test. ANOVA was conducted with changes in intention of vaccination before and after intervention as the dependent variable and the group assignment as the independent variable. Tukey&#x02019;s test was conducted on significant main effects where appropriate. A <italic>p</italic>-value of &#x0003c;0.05 was set as significant in all statistical tests. All following <italic>p</italic>-values presented in the results of Tukey&#x02019;s test, the Games&#x02013;Howell <italic>post hoc</italic> test, and Bonferroni <italic>post hoc</italic> analyses were adjusted for multiple comparison. All statistical analyses were performed using IBM SPSS Statistics for Windows, Version 21.0 (IBM Corp., Armonk, NY, USA).</p></sec></sec><sec id="S3"><title>Results</title><sec id="S3-1"><title>Participant Characteristics</title><p>Numbers of participants were 394 in a group that received statistical messages only, 408 in a group that received a patient&#x02019;s narrative messages in addition to statistical messages, 411 in a group that received a mother&#x02019;s narrative messages in addition to statistical messages, and 219 in a control group. Table <xref ref-type="table" rid="T1">1</xref> shows the participants&#x02019; baseline characteristics. Participant age ranged from 30 to 61&#x02009;years (mean&#x02009;=&#x02009;44&#x02009;years, SD&#x02009;=&#x02009;4.7). 49.7% of their daughters were 12&#x02013;14&#x02009;years old, and the remaining were 15&#x02013;16&#x02009;years old. Participants were distributed throughout Japan. About 90% of participants were not advised by health professionals to have their daughter(s) receive the HPV vaccine. About 90% of participants knew the media coverage of adverse reactions to the HPV vaccine and suspension of the proactive recommendation for HPV vaccination by the government. About 10% of participants had histories of cervical cancer or sexually transmitted disease personally or familiar persons.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Participant sociodemographic information, history, and baseline intention of vaccination.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="center" rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1">Statistics only (<italic>n</italic>&#x02009;=&#x02009;394)</th><th valign="top" align="center" rowspan="1" colspan="1">Statistics and patient&#x02019;s narrative (<italic>n</italic>&#x02009;=&#x02009;408)</th><th valign="top" align="center" rowspan="1" colspan="1">Statistics and mother&#x02019;s narrative (<italic>n</italic>&#x02009;=&#x02009;411)</th><th valign="top" align="center" rowspan="1" colspan="1">Control (<italic>n</italic>&#x02009;=&#x02009;219)</th><th valign="top" align="center" rowspan="1" colspan="1">Total (<italic>n</italic>&#x02009;=&#x02009;1,432)</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Age, mean years (SD)</td><td align="center" valign="top" rowspan="1" colspan="1">44.2 (4.6)</td><td align="center" valign="top" rowspan="1" colspan="1">43.9 (4.6)</td><td align="center" valign="top" rowspan="1" colspan="1">44.2 (4.9)</td><td align="center" valign="top" rowspan="1" colspan="1">43.8 (4.6)</td><td align="center" valign="top" rowspan="1" colspan="1">44.1 (4.7)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Age of daughters, %</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;12&#x02013;14&#x02009;years old</td><td align="center" valign="top" rowspan="1" colspan="1">50.5</td><td align="center" valign="top" rowspan="1" colspan="1">49.0</td><td align="center" valign="top" rowspan="1" colspan="1">48.9</td><td align="center" valign="top" rowspan="1" colspan="1">50.7</td><td align="center" valign="top" rowspan="1" colspan="1">49.7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;15&#x02013;16&#x02009;years old</td><td align="center" valign="top" rowspan="1" colspan="1">49.5</td><td align="center" valign="top" rowspan="1" colspan="1">51.0</td><td align="center" valign="top" rowspan="1" colspan="1">51.1</td><td align="center" valign="top" rowspan="1" colspan="1">49.3</td><td align="center" valign="top" rowspan="1" colspan="1">50.3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Highest education, %</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Less than high school</td><td align="center" valign="top" rowspan="1" colspan="1">3.3</td><td align="center" valign="top" rowspan="1" colspan="1">2.7</td><td align="center" valign="top" rowspan="1" colspan="1">3.4</td><td align="center" valign="top" rowspan="1" colspan="1">3.2</td><td align="center" valign="top" rowspan="1" colspan="1">3.1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;High school graduate</td><td align="center" valign="top" rowspan="1" colspan="1">30.2</td><td align="center" valign="top" rowspan="1" colspan="1">30.6</td><td align="center" valign="top" rowspan="1" colspan="1">29.2</td><td align="center" valign="top" rowspan="1" colspan="1">31.5</td><td align="center" valign="top" rowspan="1" colspan="1">30.2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Some college</td><td align="center" valign="top" rowspan="1" colspan="1">41.1</td><td align="center" valign="top" rowspan="1" colspan="1">40.4</td><td align="center" valign="top" rowspan="1" colspan="1">43.8</td><td align="center" valign="top" rowspan="1" colspan="1">47.5</td><td align="center" valign="top" rowspan="1" colspan="1">42.7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;College graduate</td><td align="center" valign="top" rowspan="1" colspan="1">23.6</td><td align="center" valign="top" rowspan="1" colspan="1">25.5</td><td align="center" valign="top" rowspan="1" colspan="1">23.1</td><td align="center" valign="top" rowspan="1" colspan="1">17.4</td><td align="center" valign="top" rowspan="1" colspan="1">23.1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Graduate school</td><td align="center" valign="top" rowspan="1" colspan="1">1.8</td><td align="center" valign="top" rowspan="1" colspan="1">0.7</td><td align="center" valign="top" rowspan="1" colspan="1">0.5</td><td align="center" valign="top" rowspan="1" colspan="1">0.5</td><td align="center" valign="top" rowspan="1" colspan="1">0.9</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Household income, %</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Less than 2 million yen<xref ref-type="table-fn" rid="tfn1"><sup>a</sup></xref></td><td align="center" valign="top" rowspan="1" colspan="1">7.4</td><td align="center" valign="top" rowspan="1" colspan="1">7.1</td><td align="center" valign="top" rowspan="1" colspan="1">7.1</td><td align="center" valign="top" rowspan="1" colspan="1">10.5</td><td align="center" valign="top" rowspan="1" colspan="1">7.7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;2&#x02013;6 million yen<xref ref-type="table-fn" rid="tfn1"><sup>a</sup></xref></td><td align="center" valign="top" rowspan="1" colspan="1">34.5</td><td align="center" valign="top" rowspan="1" colspan="1">36.5</td><td align="center" valign="top" rowspan="1" colspan="1">37.0</td><td align="center" valign="top" rowspan="1" colspan="1">34.2</td><td align="center" valign="top" rowspan="1" colspan="1">35.8</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;More than 6 million yen<xref ref-type="table-fn" rid="tfn1"><sup>a</sup></xref></td><td align="center" valign="top" rowspan="1" colspan="1">43.4</td><td align="center" valign="top" rowspan="1" colspan="1">42.9</td><td align="center" valign="top" rowspan="1" colspan="1">41.6</td><td align="center" valign="top" rowspan="1" colspan="1">42.5</td><td align="center" valign="top" rowspan="1" colspan="1">42.6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Unknown</td><td align="center" valign="top" rowspan="1" colspan="1">14.7</td><td align="center" valign="top" rowspan="1" colspan="1">13.5</td><td align="center" valign="top" rowspan="1" colspan="1">14.4</td><td align="center" valign="top" rowspan="1" colspan="1">12.8</td><td align="center" valign="top" rowspan="1" colspan="1">14.0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Advised by health professionals to have their daughter(s) receive human papillomavirus (HPV) vaccines, %</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" valign="top" rowspan="1" colspan="1">8.1</td><td align="center" valign="top" rowspan="1" colspan="1">6.1</td><td align="center" valign="top" rowspan="1" colspan="1">6.3</td><td align="center" valign="top" rowspan="1" colspan="1">5.5</td><td align="center" valign="top" rowspan="1" colspan="1">6.6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;No</td><td align="center" valign="top" rowspan="1" colspan="1">91.9</td><td align="center" valign="top" rowspan="1" colspan="1">93.9</td><td align="center" valign="top" rowspan="1" colspan="1">93.7</td><td align="center" valign="top" rowspan="1" colspan="1">94.5</td><td align="center" valign="top" rowspan="1" colspan="1">93.4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Knew about media coverage of adverse reactions to HPV vaccines, %</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" valign="top" rowspan="1" colspan="1">87.6</td><td align="center" valign="top" rowspan="1" colspan="1">89.2</td><td align="center" valign="top" rowspan="1" colspan="1">91.5</td><td align="center" valign="top" rowspan="1" colspan="1">93.6</td><td align="center" valign="top" rowspan="1" colspan="1">90.1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;No</td><td align="center" valign="top" rowspan="1" colspan="1">12.4</td><td align="center" valign="top" rowspan="1" colspan="1">10.8</td><td align="center" valign="top" rowspan="1" colspan="1">8.5</td><td align="center" valign="top" rowspan="1" colspan="1">6.4</td><td align="center" valign="top" rowspan="1" colspan="1">9.9</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Knew about suspension of the proactive recommendation for HPV vaccination by the government, %</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" valign="top" rowspan="1" colspan="1">84.0</td><td align="center" valign="top" rowspan="1" colspan="1">86.5</td><td align="center" valign="top" rowspan="1" colspan="1">86.9</td><td align="center" valign="top" rowspan="1" colspan="1">86.3</td><td align="center" valign="top" rowspan="1" colspan="1">85.9</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;No</td><td align="center" valign="top" rowspan="1" colspan="1">16.0</td><td align="center" valign="top" rowspan="1" colspan="1">13.5</td><td align="center" valign="top" rowspan="1" colspan="1">13.1</td><td align="center" valign="top" rowspan="1" colspan="1">13.7</td><td align="center" valign="top" rowspan="1" colspan="1">14.1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">History of cervical cancer including familiar persons, %</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" valign="top" rowspan="1" colspan="1">7.4</td><td align="center" valign="top" rowspan="1" colspan="1">10.0</td><td align="center" valign="top" rowspan="1" colspan="1">9.5</td><td align="center" valign="top" rowspan="1" colspan="1">8.2</td><td align="center" valign="top" rowspan="1" colspan="1">8.9</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;No</td><td align="center" valign="top" rowspan="1" colspan="1">92.4</td><td align="center" valign="top" rowspan="1" colspan="1">89.0</td><td align="center" valign="top" rowspan="1" colspan="1">90.5</td><td align="center" valign="top" rowspan="1" colspan="1">91.3</td><td align="center" valign="top" rowspan="1" colspan="1">90.7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;No answer</td><td align="center" valign="top" rowspan="1" colspan="1">0.3</td><td align="center" valign="top" rowspan="1" colspan="1">1.0</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">0.5</td><td align="center" valign="top" rowspan="1" colspan="1">0.4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">History of cancer other than cervical cancer including familiar persons, %</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" valign="top" rowspan="1" colspan="1">15.7</td><td align="center" valign="top" rowspan="1" colspan="1">21.3</td><td align="center" valign="top" rowspan="1" colspan="1">17.5</td><td align="center" valign="top" rowspan="1" colspan="1">19.2</td><td align="center" valign="top" rowspan="1" colspan="1">18.4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;No</td><td align="center" valign="top" rowspan="1" colspan="1">84.0</td><td align="center" valign="top" rowspan="1" colspan="1">78.2</td><td align="center" valign="top" rowspan="1" colspan="1">82.0</td><td align="center" valign="top" rowspan="1" colspan="1">80.8</td><td align="center" valign="top" rowspan="1" colspan="1">81.3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;No answer</td><td align="center" valign="top" rowspan="1" colspan="1">0.3</td><td align="center" valign="top" rowspan="1" colspan="1">0.5</td><td align="center" valign="top" rowspan="1" colspan="1">0.5</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">0.3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">History of sexually transmitted disease including familiar persons, %</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" valign="top" rowspan="1" colspan="1">7.6</td><td align="center" valign="top" rowspan="1" colspan="1">9.8</td><td align="center" valign="top" rowspan="1" colspan="1">8.3</td><td align="center" valign="top" rowspan="1" colspan="1">7.3</td><td align="center" valign="top" rowspan="1" colspan="1">8.4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;No</td><td align="center" valign="top" rowspan="1" colspan="1">92.1</td><td align="center" valign="top" rowspan="1" colspan="1">89.2</td><td align="center" valign="top" rowspan="1" colspan="1">90.0</td><td align="center" valign="top" rowspan="1" colspan="1">91.8</td><td align="center" valign="top" rowspan="1" colspan="1">90.6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;No answer</td><td align="center" valign="top" rowspan="1" colspan="1">0.3</td><td align="center" valign="top" rowspan="1" colspan="1">1.0</td><td align="center" valign="top" rowspan="1" colspan="1">1.7</td><td align="center" valign="top" rowspan="1" colspan="1">0.9</td><td align="center" valign="top" rowspan="1" colspan="1">1.0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Intention of vaccination before reading the intervention material, mean (SD)</td><td align="center" valign="top" rowspan="1" colspan="1">2.56 (0.96)</td><td align="center" valign="top" rowspan="1" colspan="1">2.53 (0.91)</td><td align="center" valign="top" rowspan="1" colspan="1">2.41 (0.94)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;</td><td align="center" valign="top" rowspan="1" colspan="1">2.50 (0.94)</td></tr></tbody></table><table-wrap-foot><fn id="tfn1"><p><italic><sup>a</sup>One US dollar is roughly equivalent to 100 yen</italic>.</p></fn></table-wrap-foot></table-wrap></sec><sec id="S3-2"><title>Intervention Effect</title><p>Internal consistencies of questions about intention to have one&#x02019;s daughter(s) receive the HPV vaccine and questions about attitude toward vaccination were excellent (Cronbach&#x02019;s &#x003b1;&#x02009;=&#x02009;0.952, M&#x02009;=&#x02009;2.73, SD&#x02009;=&#x02009;0.99 in intention; Cronbach&#x02019;s &#x003b1;&#x02009;=&#x02009;0.945, M&#x02009;=&#x02009;3.02, SD&#x02009;=&#x02009;0.98 in attitude). Table <xref ref-type="table" rid="T2">2</xref> shows the intention of and attitude toward HPV vaccination across groups. Regarding intention of vaccination, ANOVA revealed a main effect of the group assignment [<italic>F</italic>(3, 1,428)&#x02009;=&#x02009;17.198, MSE&#x02009;=&#x02009;0.957, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001, &#x003b7;<sup>2</sup>&#x02009;=&#x02009;0.035]. Tukey&#x02019;s test revealed a significant difference between the control and the statistics only (M&#x02009;=&#x02009;2.30 vs. M&#x02009;=&#x02009;2.81, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001), the control and the patient&#x02019;s narrative in addition to statistics (M&#x02009;=&#x02009;2.30 vs. M&#x02009;=&#x02009;2.85, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001), and the control and the mother&#x02019;s narrative in addition to statistics (M&#x02009;=&#x02009;2.30 vs. M&#x02009;=&#x02009;2.77, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001) groups. There was no significant difference in intention of vaccination between the three intervention groups. Regarding attitude toward vaccination, ANOVA revealed a main effect of the group assignment [<italic>F</italic>(3, 1,428)&#x02009;=&#x02009;42.553, MSE&#x02009;=&#x02009;1.645, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001, &#x003b7;<sup>2</sup>&#x02009;=&#x02009;0.082]. The Games&#x02013;Howell <italic>post hoc</italic> test revealed a significant difference between the control and the statistics only (M&#x02009;=&#x02009;2.39 vs. M =&#x02009;3.10, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001), the control and the patient&#x02019;s narrative in addition to statistics (M&#x02009;=&#x02009;2.39 vs. M =&#x02009;3.21, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001), and the control and the mother&#x02019;s narrative in addition to statistics (M&#x02009;=&#x02009;2.39 vs. M =&#x02009;3.12, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001) groups. There was no significant difference in attitude between the three intervention groups.</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Intention of and attitude toward human papillomavirus vaccination across groups.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="center" rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1">Statistics only (<italic>n</italic>&#x02009;=&#x02009;394)</th><th valign="top" align="center" rowspan="1" colspan="1">Patient&#x02019;s narrative in addition to statistics (<italic>n</italic>&#x02009;=&#x02009;408)</th><th valign="top" align="center" rowspan="1" colspan="1">Mother&#x02019;s narrative in addition to statistics (<italic>n</italic>&#x02009;=&#x02009;411)</th><th valign="top" align="center" rowspan="1" colspan="1">Control (<italic>n</italic>&#x02009;=&#x02009;219)</th><th valign="top" align="center" rowspan="1" colspan="1"><italic>p</italic></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Intention of vaccination, mean (SD)<xref ref-type="table-fn" rid="tfn2"><sup>a</sup></xref></td><td align="center" valign="top" rowspan="1" colspan="1">2.81 (1.00)</td><td align="center" valign="top" rowspan="1" colspan="1">2.85 (1.01)</td><td align="center" valign="top" rowspan="1" colspan="1">2.77 (0.96)</td><td align="center" valign="top" rowspan="1" colspan="1">2.30 (0.90)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Attitude toward vaccination, mean (SD)</td><td align="center" valign="top" rowspan="1" colspan="1">3.10 (1.00)</td><td align="center" valign="top" rowspan="1" colspan="1">3.21 (0.98)</td><td align="center" valign="top" rowspan="1" colspan="1">3.12 (0.90)</td><td align="center" valign="top" rowspan="1" colspan="1">2.39 (0.85)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Intention of vaccination, estimated mean after adjusting for baseline intention (95% CI)<xref ref-type="table-fn" rid="tfn2"><sup>a</sup></xref></td><td align="center" valign="top" rowspan="1" colspan="1">2.76 (2.71&#x02013;2.81)</td><td align="center" valign="top" rowspan="1" colspan="1">2.82 (2.77&#x02013;2.87)</td><td align="center" valign="top" rowspan="1" colspan="1">2.84 (2.80&#x02013;2.89)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02013;</td><td align="center" valign="top" rowspan="1" colspan="1">0.038</td></tr></tbody></table><table-wrap-foot><p><italic>CI, confidence interval</italic>.</p><fn id="tfn2"><p><italic><sup>a</sup>Intention after intervention except for a control condition</italic>.</p></fn></table-wrap-foot></table-wrap><p>Analysis of covariance with the baseline intention set as the covariate revealed the main effect of the group assignment [<italic>F</italic>(2, 1,209)&#x02009;=&#x02009;3.287, MSE&#x02009;=&#x02009;0.255, <italic>p</italic>&#x02009;=&#x02009;0.038, &#x003b7;<sup>2</sup>&#x02009;=&#x02009;0.0014]. The estimated means of intention after intervention with the covariate adjustment for baseline values are shown in Table <xref ref-type="table" rid="T2">2</xref>. Bonferroni <italic>post hoc</italic> analyses revealed a significant difference between the statistics only and the mother&#x02019;s narrative in addition to statistics groups (M&#x02009;=&#x02009;2.76 vs. M&#x02009;=&#x02009;2.84, <italic>p</italic>&#x02009;=&#x02009;0.040). There was no significant difference in the estimated means of intention between the statistics only and the patient&#x02019;s narrative in addition to statistics groups.</p><p>The mean of intention to have one&#x02019;s daughter(s) receive the HPV vaccine before and after intervention in the three intervention groups was 2.50 (SD&#x02009;=&#x02009;0.94) and 2.81 (SD&#x02009;=&#x02009;0.99), respectably. Figure <xref ref-type="fig" rid="F1">1</xref> shows distributions of intention of vaccination before and after intervention. Table <xref ref-type="table" rid="T3">3</xref> shows changes in intention of vaccination before and after intervention across groups. The paired <italic>t</italic>-test revealed significant changes in intention before and after intervention in the all intervention groups (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001). ANOVA revealed a main effect of the group assignment [<italic>F</italic>(2, 1,210)&#x02009;=&#x02009;4.078, MSE&#x02009;=&#x02009;0.262, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.017, &#x003b7;<sup>2</sup>&#x02009;=&#x02009;0.007]. Tukey&#x02019;s test revealed a significant difference of change amount between the statistics only and the mother&#x02019;s narrative in addition to statistics groups (M&#x02009;=&#x02009;0.25 vs. M&#x02009;=&#x02009;0.35, <italic>p</italic>&#x02009;=&#x02009;0.014). There was no significant difference in change amount between the statistics only and the patient&#x02019;s narrative in addition to statistics groups.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Distributions of intention of vaccination before and after intervention.</p></caption><graphic xlink:href="fpubh-06-00105-g001"/></fig><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Changes in intention of vaccination before and after intervention across groups.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="3" colspan="1"/><th valign="top" align="center" colspan="3" rowspan="1">Statistics only (<italic>n</italic>&#x02009;=&#x02009;394)</th><th valign="top" align="center" colspan="3" rowspan="1">Statistics and patient&#x02019;s narrative (<italic>n</italic>&#x02009;=&#x02009;408)</th><th valign="top" align="center" colspan="3" rowspan="1">Statistics and mother&#x02019;s narrative (<italic>n</italic>&#x02009;=&#x02009;411)</th><th valign="top" align="center" rowspan="3" colspan="1"><italic>p</italic><xref ref-type="table-fn" rid="tfn4"><sup>b</sup></xref></th></tr><tr><td align="center" valign="top" colspan="3" rowspan="1"><hr/></td><td align="center" valign="top" colspan="3" rowspan="1"><hr/></td><td align="center" valign="top" colspan="3" rowspan="1"><hr/></td></tr><tr><th valign="top" align="center" rowspan="1" colspan="1">Before</th><th valign="top" align="center" rowspan="1" colspan="1">After</th><th valign="top" align="center" rowspan="1" colspan="1"><italic>p</italic><xref ref-type="table-fn" rid="tfn3"><sup>a</sup></xref></th><th valign="top" align="center" rowspan="1" colspan="1">Before</th><th valign="top" align="center" rowspan="1" colspan="1">After</th><th valign="top" align="center" rowspan="1" colspan="1"><italic>p</italic><xref ref-type="table-fn" rid="tfn3"><sup>a</sup></xref></th><th valign="top" align="center" rowspan="1" colspan="1">Before</th><th valign="top" align="center" rowspan="1" colspan="1">After</th><th valign="top" align="center" rowspan="1" colspan="1"><italic>p</italic><xref ref-type="table-fn" rid="tfn3"><sup>a</sup></xref></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Intention of vaccination, mean (SD)</td><td align="center" valign="top" rowspan="1" colspan="1">2.56 (0.96)</td><td align="center" valign="top" rowspan="1" colspan="1">2.81 (1.00)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">2.53 (0.91)</td><td align="center" valign="top" rowspan="1" colspan="1">2.85 (1.01)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">2.41 (0.94)</td><td align="center" valign="top" rowspan="1" colspan="1">2.77 (0.96)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="top" colspan="11" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Changes in intention before and after intervention, mean (SD)</td><td align="center" valign="top" colspan="3" rowspan="1">0.25 (0.49)</td><td align="center" valign="top" colspan="3" rowspan="1">0.32 (0.53)</td><td align="center" valign="top" colspan="3" rowspan="1">0.35 (0.52)</td><td align="center" valign="top" rowspan="1" colspan="1">0.017</td></tr></tbody></table><table-wrap-foot><fn id="tfn3"><p><italic><sup>a</sup>p-Values were assessed using the paired t-test</italic>.</p></fn><fn id="tfn4"><p><italic><sup>b</sup>A p-value was assessed using analysis of variance</italic>.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec sec-type="discussion" id="S4"><title>Discussion</title><sec id="S4-1"><title>Persuasiveness of Statistical and Narrative Evidence</title><p>We conducted a randomized controlled study to compare message persuasiveness between different conditions in terms of statistics, narratives, and narrators in the context of HPV vaccine communication. This study found that statistical only messages as well as a narrative (of a patient or a mother) in addition to statistical messages significantly improved mothers&#x02019; attitude and intention to have their daughter(s) receive the HPV vaccine than a no message condition (control). This result is consistent with a number of studies that showed presenting statistical or narrative evidence enhances message persuasiveness (<xref rid="B10" ref-type="bibr">10</xref>&#x02013;<xref rid="B12" ref-type="bibr">12</xref>).</p></sec><sec id="S4-2"><title>Persuasiveness of Patient&#x02019; vs. Mother&#x02019; Narrative</title><p>One of our research questions was: will the narrative of a mother whose daughter experienced cervical cancer result in higher intention to have their daughters receive the HPV vaccine than the narrative of a patient who experienced cervical cancer among participants who are mothers with daughters? This study found no significant difference in attitude and intention of vaccination between the statistics only, patient&#x02019;s narrative in addition to statistics, and mother&#x02019;s narrative in addition to statistics groups. One of the reasons may be that baseline intentions affected intentions after reading the material; the baseline intention was the highest in the statistics only group (M&#x02009;=&#x02009;2.56) and the lowest in the mother&#x02019;s narrative in addition to statistics group (M&#x02009;=&#x02009;2.41) (see Table <xref ref-type="table" rid="T1">1</xref>). The estimated mean of intention after adjusting for baseline intentions in the mother&#x02019;s narrative in addition to statistics group was the highest among intervention groups, and significantly higher than in the statistics only group. In addition, the change in intention of vaccination before and after intervention in the mother&#x02019;s narrative in addition to statistics group was the largest among intervention groups, and significantly larger than in the statistics only group, although this result should be interpreted with caution because the regression to the mean of baseline values may be mixed in those changes (<xref rid="B51" ref-type="bibr">51</xref>). Similarity of the audience to a narrator should increase the likelihood of identification and consequently persuasiveness of the narrative message (<xref rid="B30" ref-type="bibr">30</xref>&#x02013;<xref rid="B41" ref-type="bibr">41</xref>). The mother&#x02019;s narrative may have been easy to feel similar to and identify with for participants who were mothers with daughters and consequently contributed to increase mothers&#x02019; vaccination intentions.</p><p>However, even after adjusting for baseline intentions, we found no significant difference in vaccination intention between the patient&#x02019;s narrative in addition to statistics and the mother&#x02019;s narrative in addition to statistics groups. This may be because other factors such as increase in self-efficacy through modeling (<xref rid="B28" ref-type="bibr">28</xref>) and generation of fewer counterarguments (<xref rid="B26" ref-type="bibr">26</xref>) were more important than identification with the narrator in HPV vaccine communication. Future studies focusing on other factors such as modeling may be useful; e.g., a study that uses the narrative of a mother who had her daughter receives the HPV vaccine.</p></sec><sec id="S4-3"><title>Persuasiveness of Statistics Only vs. Statistics in Addition to Narrative</title><p>Another of our research questions was: will a narrative message in addition to statistical messages result in higher intention to receive the HPV vaccine than statistical messages only under the circumstances of the HPV vaccination crisis in Japan? We found no significant difference in vaccination intention between the statistics only and the patient&#x02019;s narrative in addition to statistics groups before as well as after adjusting for baseline intentions. The process of identification involves multiple dimensions such as sharing the character&#x02019;s feelings and perspective, internalizing the character&#x02019;s goals, and the loss of self-awareness by being absorbed in the story (<xref rid="B32" ref-type="bibr">32</xref>). Considering this, the narrative message used in the present study was created for research purposes and therefore may have been too short and dull without a picture or the name of the narrator to develop the process of identification for the audience. It may be useful to examine the persuasiveness of a longer and more vivid narrative of cervical cancer experience in future studies so that the audience can develop the process of identification.</p></sec><sec id="S4-4"><title>Limitations</title><p>The findings of this study must be interpreted with several limitations. First, narrative persuasion is generally hindered when the persuasive intent is obvious, as in the intervention materials of the present study, because some audiences may react against being manipulated (<xref rid="B52" ref-type="bibr">52</xref>). This constraint of intervention materials in this study should be noted in addition to shortness and dullness as discussed above. Second, although previous studies assessed the degree of identification with characters in terms of components such as liking, feeling like you know, and wanting to be like, we did not assess the degree of identification because such measurement items were not applicable to the narratives in the present study. However, mothers may obviously identify more with a mother&#x02019;s narrative than a patient&#x02019;s narrative because similarity of the audience to a narrator should increase the likelihood of identification (<xref rid="B32" ref-type="bibr">32</xref>). Third, this study assessed vaccination intentions directly after message exposure. The long-term effects of promotional messages should be examined in future studies because they are important in this context given that HPV vaccination requires multiple injections over a series of weeks. Fourth, this study assessed vaccination intentions rather than actual vaccination behaviors. However, measuring intention is beneficial in public health studies because it predicts actual behaviors (<xref rid="B53" ref-type="bibr">53</xref>). Finally, considering the critical situation of HPV vaccination in Japan, participants&#x02019; prior attitudes toward and intentions of vaccination may have been negatively distorted and affected the study results. Therefore, our results should be interpreted with caution.</p></sec></sec><sec id="S5"><title>Conclusion</title><p>Statistical messages of HPV vaccine efficacy and safety, the narrative of a patient who experienced cervical cancer in addition to statistical messages, and the narrative of a mother whose daughter experienced cervical cancer in addition to statistical messages increased vaccination intention among participants who were mothers with daughters. In the practice of HPV vaccine communication, exposure to messages of HPV vaccine efficacy and safety may increase a mother&#x02019;s vaccination intention whether it includes only statistical messages or narratives of cervical cancer experience in addition to statistical messages. Our study results may indicate that active dissemination of messages about efficacy and safety of HPV vaccines by public health institutions including the Ministry of Health, Labor, and Welfare and mother&#x02019;s exposure to those messages are the keys to improve their attitude toward and intention of HPV vaccination.</p><p>A mother&#x02019;s narrative in addition to statistical messages resulted in slightly higher vaccination intention than statistical messages only and a patient&#x02019;s narrative message in addition to statistical messages. Mothers may feel similar to and easily identify with a mother&#x02019;s narrative. Narrative of a mother with a daughter who experienced cervical cancer may be persuasive for audiences who are mothers. The public health institutions including the Ministry of Health, Labor, and Welfare may be able to increase persuasiveness of HPV vaccination recommendation messages by using the narrative of a mother&#x02019;s daughter experienced cervical cancer in addition to statistical messages when they create materials such as leaflets and websites.</p><p>However, further studies are needed to understand more about persuasive differences between statistical and narrative messages as well as factors influencing the persuasiveness of narratives. A deeper understanding of these factors will help health professionals to more effectively communicate with individuals and communities to encourage better decision making regarding HPV vaccination.</p></sec><sec id="S6"><title>Ethics Statement</title><p>This study was carried out in accordance with the recommendations of the ethical review committee at the Graduate School of Medicine, The University of Tokyo. The protocol was approved by the ethical review committee at the Graduate School of Medicine, The University of Tokyo. All subjects gave written informed consent in accordance with the Declaration of Helsinki.</p></sec><sec id="S7"><title>Author Contributions</title><p>TO and HI conceived the concept and design of the study. TO conducted statistical analysis and wrote the manuscript. HI provided the first feedback for the manuscript. All authors discussed the manuscript critically and approved the final version.</p></sec><sec id="S8"><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><ack><p>We thank Christina Croney, PhD, from Edanz Group (<uri xlink:type="simple" xlink:href="http://www.edanzediting.com/ac">www.edanzediting.com/ac</uri>), for editing a draft of this manuscript.</p></ack><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This study was supported by JSPS KAKENHI (grant number 167100000384).</p></fn></fn-group><sec id="S10" sec-type="supplementary-material"><title>Supplementary Material</title><p>The Supplementary Material for this article can be found online at <uri xlink:type="simple" xlink:href="https://www.frontiersin.org/articles/10.3389/fpubh.2018.00105/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fpubh.2018.00105/full#supplementary-material</uri>.</p><supplementary-material content-type="local-data" id="SM1"><media xlink:href="data_sheet_1.PDF"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec><sec id="S11"><title>Abbreviations</title><p>HPV, human papillomavirus; ANOVA, analysis of variance; ANCOVA, analysis of covariance; CONSORT, Consolidated Standards of Reporting Trials.</p></sec><ref-list><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="book"><collab>U.S. Department of Health and Human Services</collab>. <article-title>Health communication</article-title>. <edition>2nd ed</edition>
<source>Healthy People 2010: Understanding and Improving Health</source>. (Chap. 11), <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>U.S. Government Printing Office</publisher-name> (<year>2000</year>). Available from: <uri xlink:type="simple" xlink:href="https://www.healthypeople.gov/2010/Document/pdf/Volume1/11HealthCom.pdf">https://www.healthypeople.gov/2010/Document/pdf/Volume1/11HealthCom.pdf</uri></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanley</surname><given-names>S</given-names></name><name><surname>Yoshioka</surname><given-names>E</given-names></name><name><surname>Ito</surname><given-names>Y</given-names></name><name><surname>Kishi</surname><given-names>R</given-names></name></person-group>
<article-title>HPV vaccination crisis in Japan</article-title>. <source>Lancet</source> (<year>2015</year>) <volume>385</volume>(<issue>9987</issue>):<fpage>2571</fpage><pub-id pub-id-type="doi">10.1016/S0140-6736(15)61152-7</pub-id><pub-id pub-id-type="pmid">26122153</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larson</surname><given-names>H</given-names></name><name><surname>Wilson</surname><given-names>R</given-names></name><name><surname>Hanley</surname><given-names>S</given-names></name><name><surname>Parys</surname><given-names>A</given-names></name><name><surname>Paterson</surname><given-names>P</given-names></name></person-group>. <article-title>Tracking the global spread of vaccine sentiments: the global response to Japan&#x02019;s suspension of its HPV vaccine recommendation</article-title>. <source>Hum Vaccin Immunother</source> (<year>2014</year>) <volume>10</volume>(<issue>9</issue>):<fpage>2543</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="doi">10.4161/21645515.2014.969618</pub-id><pub-id pub-id-type="pmid">25483472</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dornbusch</surname><given-names>H</given-names></name><name><surname>Stiris</surname><given-names>T</given-names></name><name><surname>Del Torso</surname><given-names>S</given-names></name><name><surname>Ross-Russell</surname><given-names>R</given-names></name><name><surname>Zavrsnik</surname><given-names>J</given-names></name><name><surname>Wettergren</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>Human papillomavirus vaccination crisis in Japan</article-title>. <source>J Paediatr Child Health</source> (<year>2015</year>) <volume>51</volume>(<issue>12</issue>):<fpage>1146</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1111/jpc.13020</pub-id><pub-id pub-id-type="pmid">26633608</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darden</surname><given-names>PM</given-names></name><name><surname>Thompson</surname><given-names>DM</given-names></name><name><surname>Roberts</surname><given-names>JR</given-names></name><name><surname>Hale</surname><given-names>JJ</given-names></name><name><surname>Pope</surname><given-names>C</given-names></name><name><surname>Naifeh</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Reasons for not vaccinating adolescents: national immunization survey of teens, 2008&#x02013;2010</article-title>. <source>Pediatrics</source> (<year>2013</year>) <volume>131</volume>:<fpage>645</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="doi">10.1542/peds.2012-2384</pub-id><pub-id pub-id-type="pmid">23509163</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>A</given-names></name><name><surname>Ngai</surname><given-names>K</given-names></name><name><surname>Chor</surname><given-names>J</given-names></name><name><surname>Chan</surname><given-names>P</given-names></name></person-group>. <article-title>Knowledge, attitude, practice and barriers on vaccination against human papillomavirus infection: a cross-sectional study among primary care physicians in Hong Kong</article-title>. <source>PLoS One</source> (<year>2013</year>) <volume>8</volume>(<issue>8</issue>):<fpage>e71827</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0071827</pub-id><pub-id pub-id-type="pmid">23990994</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sotiriadis</surname><given-names>A</given-names></name><name><surname>Dagklis</surname><given-names>T</given-names></name><name><surname>Siamanta</surname><given-names>V</given-names></name><name><surname>Chatzigeorgiou</surname><given-names>K</given-names></name><name><surname>Agorastos</surname><given-names>T</given-names></name><collab>LYSISTRATA Study Group</collab></person-group>. <article-title>Increasing fear of adverse effects drops intention to vaccinate after the introduction of prophylactic HPV vaccine</article-title>. <source>Arch Gynecol Obstet</source> (<year>2012</year>) <volume>285</volume>(<issue>6</issue>):<fpage>1719</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="doi">10.1007/s00404-011-2208-z</pub-id><pub-id pub-id-type="pmid">22246478</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><collab>World Health Organization</collab>. <article-title>Meeting of the global advisory committee on vaccine safety, 7&#x02013;8 June 2017</article-title>. <source>Wkly Epidemiol Rec</source> (<year>2017</year>) <volume>92</volume>(<issue>28</issue>):<fpage>393</fpage>&#x02013;<lpage>402</lpage>. Available from: <uri xlink:type="simple" xlink:href="http://apps.who.int/iris/bitstream/10665/255870/1/WER9228.pdf?ua=1">http://apps.who.int/iris/bitstream/10665/255870/1/WER9228.pdf?ua=1</uri><pub-id pub-id-type="pmid">28707463</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwata</surname><given-names>S</given-names></name><name><surname>Okada</surname><given-names>K</given-names></name><name><surname>Kawana</surname><given-names>K</given-names></name></person-group>
<article-title>Consensus statement from 17 relevant Japanese academic societies on the promotion of the human papillomavirus vaccine</article-title>. <source>Vaccine</source> (<year>2017</year>) <volume>35</volume>(<issue>18</issue>):<fpage>2291</fpage>&#x02013;<lpage>2</lpage>.<pub-id pub-id-type="doi">10.1016/j.vaccine.2017.03.015</pub-id><pub-id pub-id-type="pmid">28325478</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinard</surname><given-names>J</given-names></name></person-group>
<article-title>The empirical study of the persuasive effects of evidence: the status after fifty years of research</article-title>. <source>Hum Commun Res</source> (<year>1988</year>) <volume>15</volume>(<issue>1</issue>):<fpage>3</fpage>&#x02013;<lpage>59</lpage>.<pub-id pub-id-type="doi">10.1111/j.1468-2958.1988.tb00170.x</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>M</given-names></name><name><surname>Preiss</surname><given-names>R</given-names></name></person-group>
<article-title>Comparing the persuasiveness of narrative and statistical evidence using meta-analysis</article-title>. <source>Commun Res Rep</source> (<year>1997</year>) <volume>14</volume>(<issue>2</issue>):<fpage>125</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="doi">10.1080/08824099709388654</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Allen</surname><given-names>M</given-names></name><name><surname>Gattoni</surname><given-names>A</given-names></name><name><surname>Grimes</surname><given-names>D</given-names></name><name><surname>Herrman</surname><given-names>AM</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Testing an additive model for the effectiveness of evidence on the persuasiveness of a message</article-title>. <source>Soc Influence</source> (<year>2012</year>) <volume>7</volume>(<issue>2</issue>):<fpage>65</fpage>&#x02013;<lpage>77</lpage>.<pub-id pub-id-type="doi">10.1080/15534510.2012.658285</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winterbottom</surname><given-names>A</given-names></name><name><surname>Bekker</surname><given-names>H</given-names></name><name><surname>Conner</surname><given-names>M</given-names></name><name><surname>Mooney</surname><given-names>A</given-names></name></person-group>. <article-title>Does narrative information bias individual&#x02019;s decision making? A systematic review</article-title>. <source>Soc Sci Med</source> (<year>2008</year>) <volume>67</volume>(<issue>12</issue>):<fpage>2079</fpage>&#x02013;<lpage>88</lpage>.<pub-id pub-id-type="doi">10.1016/j.socscimed.2008.09.037</pub-id><pub-id pub-id-type="pmid">18951673</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zebregs</surname><given-names>S</given-names></name><name><surname>van den Putte</surname><given-names>B</given-names></name><name><surname>Neijens</surname><given-names>P</given-names></name><name><surname>de Graaf</surname><given-names>A</given-names></name></person-group>. <article-title>The differential impact of statistical and narrative evidence on beliefs, attitude, and intention: a meta-analysis</article-title>. <source>Health Commun</source> (<year>2015</year>) <volume>30</volume>(<issue>3</issue>):<fpage>282</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1080/10410236.2013.842528</pub-id><pub-id pub-id-type="pmid">24836931</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinyard</surname><given-names>L</given-names></name><name><surname>Kreuter</surname><given-names>M</given-names></name></person-group>. <article-title>Using narrative communication as a tool for health behavior change: a conceptual, theoretical, and empirical overview</article-title>. <source>Health Educ Behav</source> (<year>2007</year>) <volume>34</volume>(<issue>5</issue>):<fpage>777</fpage>&#x02013;<lpage>92</lpage>.<pub-id pub-id-type="doi">10.1177/1090198106291963</pub-id><pub-id pub-id-type="pmid">17200094</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kreuter</surname><given-names>MW</given-names></name><name><surname>Green</surname><given-names>MC</given-names></name><name><surname>Cappella</surname><given-names>JN</given-names></name><name><surname>Slater</surname><given-names>MD</given-names></name><name><surname>Wise</surname><given-names>ME</given-names></name><name><surname>Storey</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Narrative communication in cancer prevention and control: a framework to guide research and application</article-title>. <source>Ann Behav Med</source> (<year>2007</year>) <volume>33</volume>(<issue>3</issue>):<fpage>221</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="doi">10.1080/08836610701357922</pub-id><pub-id pub-id-type="pmid">17600449</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braddock</surname><given-names>K</given-names></name><name><surname>Dillard</surname><given-names>J</given-names></name></person-group>
<article-title>Meta-analytic evidence for the persuasive effect of narratives on beliefs, attitudes, intentions, and behaviors</article-title>. <source>Commun Monogr</source> (<year>2016</year>) <volume>83</volume>(<issue>4</issue>):<fpage>446</fpage>&#x02013;<lpage>67</lpage>.<pub-id pub-id-type="doi">10.1080/03637751.2015.1128555</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Wit</surname><given-names>J</given-names></name><name><surname>Das</surname><given-names>E</given-names></name><name><surname>Vet</surname><given-names>R</given-names></name></person-group>. <article-title>What works best: objective statistics or a personal testimonial? An assessment of the persuasive effects of different types of message evidence on risk perception</article-title>. <source>Health Psychol</source> (<year>2008</year>) <volume>27</volume>(<issue>1</issue>):<fpage>110</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1037/0278-6133.27.1.110</pub-id><pub-id pub-id-type="pmid">18230021</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prati</surname><given-names>G</given-names></name><name><surname>Pietrantoni</surname><given-names>L</given-names></name><name><surname>Zani</surname><given-names>B</given-names></name></person-group>. <article-title>Influenza vaccination: the persuasiveness of messages among people aged 65 years and older</article-title>. <source>Health Commun</source> (<year>2012</year>) <volume>27</volume>(<issue>5</issue>):<fpage>413</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1080/10410236.2011.606523</pub-id><pub-id pub-id-type="pmid">21957983</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nan</surname><given-names>X</given-names></name><name><surname>Dahlstrom</surname><given-names>M</given-names></name><name><surname>Richards</surname><given-names>A</given-names></name><name><surname>Rangarajan</surname><given-names>S</given-names></name></person-group>. <article-title>Influence of evidence type and narrative type on HPV risk perception and intention to obtain the HPV vaccine</article-title>. <source>Health Commun</source> (<year>2015</year>) <volume>30</volume>(<issue>3</issue>):<fpage>301</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1080/10410236.2014.888629</pub-id><pub-id pub-id-type="pmid">25061715</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hopfer</surname><given-names>S</given-names></name></person-group>. <article-title>Effects of a narrative HPV vaccination intervention aimed at reaching college women: a randomized controlled trial</article-title>. <source>Prev Sci</source> (<year>2012</year>) <volume>13</volume>(<issue>2</issue>):<fpage>173</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1007/s11121-011-0254-1</pub-id><pub-id pub-id-type="pmid">21993613</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shelby</surname><given-names>A</given-names></name><name><surname>Ernst</surname><given-names>K</given-names></name></person-group>. <article-title>Story and science: how providers and parents can utilize storytelling to combat anti-vaccine misinformation</article-title>. <source>Hum Vaccin Immunother</source> (<year>2013</year>) <volume>9</volume>(<issue>8</issue>):<fpage>1795</fpage>&#x02013;<lpage>801</lpage>.<pub-id pub-id-type="doi">10.4161/hv.24828</pub-id><pub-id pub-id-type="pmid">23811786</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Betsch</surname><given-names>C</given-names></name><name><surname>Brewer</surname><given-names>NT</given-names></name><name><surname>Brocard</surname><given-names>P</given-names></name><name><surname>Davies</surname><given-names>P</given-names></name><name><surname>Gaissmaier</surname><given-names>W</given-names></name><name><surname>Haase</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Opportunities and challenges of Web 2.0 for vaccination decisions</article-title>. <source>Vaccine</source> (<year>2012</year>) <volume>30</volume>(<issue>25</issue>):<fpage>3727</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="doi">10.1016/j.vaccine.2012.02.025</pub-id><pub-id pub-id-type="pmid">22365840</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okuhara</surname><given-names>T</given-names></name><name><surname>Ishikawa</surname><given-names>H</given-names></name><name><surname>Okada</surname><given-names>M</given-names></name><name><surname>Kato</surname><given-names>M</given-names></name><name><surname>Kiuchi</surname><given-names>T</given-names></name></person-group>. <article-title>Readability comparison of pro- and anti-HPV-vaccination online messages in Japan</article-title>. <source>Patient Educ Couns</source> (<year>2017</year>) <volume>100</volume>(<issue>10</issue>):<fpage>1859</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="doi">10.1016/j.pec.2017.04.013</pub-id><pub-id pub-id-type="pmid">28532860</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okuhara</surname><given-names>T</given-names></name><name><surname>Ishikawa</surname><given-names>H</given-names></name><name><surname>Okada</surname><given-names>M</given-names></name><name><surname>Kato</surname><given-names>M</given-names></name><name><surname>Kiuchi</surname><given-names>T</given-names></name></person-group>
<article-title>Contents of Japanese pro- and anti-HPV vaccination websites: a text mining analysis</article-title>. <source>Patient Educ Couns</source> (<year>2018</year>) <volume>101</volume>(<issue>3</issue>):<fpage>406</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="doi">10.1016/j.pec.2017.09.014</pub-id><pub-id pub-id-type="pmid">29031425</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>M</given-names></name><name><surname>Brock</surname><given-names>T</given-names></name></person-group>. <article-title>The role of transportation in the persuasiveness of public narratives</article-title>. <source>J Pers Soc Psychol</source> (<year>2000</year>) <volume>79</volume>(<issue>5</issue>):<fpage>701</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="doi">10.1037/0022-3514.79.5.701</pub-id><pub-id pub-id-type="pmid">11079236</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slater</surname><given-names>M</given-names></name><name><surname>Rouner</surname><given-names>D</given-names></name></person-group>
<article-title>Entertainment-education and elaboration likelihood: understanding the processing of narrative persuasion</article-title>. <source>Commun Theory</source> (<year>2002</year>) <volume>12</volume>(<issue>2</issue>):<fpage>173</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1093/ct/12.2.173</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moyer-Gus&#x000e9;</surname><given-names>E</given-names></name></person-group>
<article-title>Toward a theory of entertainment persuasion: explaining the persuasive effects of entertainment-education messages</article-title>. <source>Commun Theory</source> (<year>2008</year>) <volume>18</volume>(<issue>3</issue>):<fpage>407</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="doi">10.1111/j.1468-2885.2008.00328.x</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>O&#x02019;Keefe</surname><given-names>DJ</given-names></name></person-group>
<source>Persuasion: Theory and Research</source>. <edition>3rd ed</edition>
<publisher-loc>Los Angeles</publisher-loc>: <publisher-name>SAGE</publisher-name> (<year>2015</year>). p. <fpage>216</fpage>&#x02013;<lpage>9</lpage>.</mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Busselle</surname><given-names>R</given-names></name><name><surname>Bilandzic</surname><given-names>H</given-names></name></person-group>
<article-title>Measuring narrative engagement</article-title>. <source>Media Psychol</source> (<year>2009</year>) <volume>12</volume>(<issue>4</issue>):<fpage>321</fpage>&#x02013;<lpage>47</lpage>.<pub-id pub-id-type="doi">10.1080/15213260903287259</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Laer</surname><given-names>T</given-names></name><name><surname>de Ruyter</surname><given-names>K</given-names></name><name><surname>Visconti</surname><given-names>L</given-names></name><name><surname>Wetzels</surname><given-names>M</given-names></name></person-group>
<article-title>The extended transportation-imagery model: a meta-analysis of the antecedents and consequences of consumers&#x02019; narrative transportation</article-title>. <source>J Consum Res</source> (<year>2014</year>) <volume>40</volume>(<issue>5</issue>):<fpage>797</fpage>&#x02013;<lpage>817</lpage>.<pub-id pub-id-type="doi">10.1086/673383</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>J</given-names></name></person-group>
<article-title>Defining Identification: a theoretical look at the identification of audiences with media characters</article-title>. <source>Mass Commun Soc</source> (<year>2001</year>) <volume>4</volume>(<issue>3</issue>):<fpage>245</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="doi">10.1207/S15327825MCS0403_01</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sestir</surname><given-names>M</given-names></name><name><surname>Green</surname><given-names>M</given-names></name></person-group>
<article-title>You are who you watch: identification and transportation effects on temporary self-concept</article-title>. <source>Soc Influence</source> (<year>2010</year>) <volume>5</volume>(<issue>4</issue>):<fpage>272</fpage>&#x02013;<lpage>88</lpage>.<pub-id pub-id-type="doi">10.1080/15534510.2010.490672</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Igartua</surname><given-names>JJ</given-names></name></person-group>
<article-title>Identification with characters and narrative persuasion through fictional feature films</article-title>. <source>Eur J Commun Res</source> (<year>2010</year>) <volume>35</volume>:<fpage>347</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1515/comm.2010.019</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moyer-Gus&#x000e9;</surname><given-names>E</given-names></name><name><surname>Chung</surname><given-names>A</given-names></name><name><surname>Jain</surname><given-names>P</given-names></name></person-group>
<article-title>Identification with characters and discussion of taboo topics after exposure to an entertainment narrative about sexual health</article-title>. <source>J Commun</source> (<year>2011</year>) <volume>61</volume>(<issue>3</issue>):<fpage>387</fpage>&#x02013;<lpage>406</lpage>.<pub-id pub-id-type="doi">10.1111/j.1460-2466.2011.01551.x</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Graaf</surname><given-names>A</given-names></name><name><surname>Hoeken</surname><given-names>H</given-names></name><name><surname>Sanders</surname><given-names>J</given-names></name><name><surname>Beentjes</surname><given-names>J</given-names></name></person-group>
<article-title>Identification as a mechanism of narrative persuasion</article-title>. <source>Commun Res</source> (<year>2012</year>) <volume>39</volume>(<issue>6</issue>):<fpage>802</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1177/0093650211408594</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>S</given-names></name><name><surname>Frank</surname><given-names>L</given-names></name><name><surname>Chatterjee</surname><given-names>J</given-names></name><name><surname>Baezconde-Garbanati</surname><given-names>L</given-names></name></person-group>
<article-title>Narrative versus nonnarrative: the role of identification, transportation, and emotion in reducing health disparities</article-title>. <source>J Commun</source> (<year>2013</year>) <volume>63</volume>(<issue>1</issue>):<fpage>116</fpage>&#x02013;<lpage>37</lpage>.<pub-id pub-id-type="doi">10.1111/jcom.12007</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoeken</surname><given-names>H</given-names></name><name><surname>Sinkeldam</surname><given-names>J</given-names></name></person-group>
<article-title>The role of identification and perception of just outcome in evoking emotions in narrative persuasion</article-title>. <source>J Commun</source> (<year>2014</year>) <volume>64</volume>(<issue>5</issue>):<fpage>935</fpage>&#x02013;<lpage>55</lpage>.<pub-id pub-id-type="doi">10.1111/jcom.12114</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Bell</surname><given-names>R</given-names></name><name><surname>Taylor</surname><given-names>L</given-names></name></person-group>
<article-title>Narrator point of view and persuasion in health narratives: the role of protagonist-reader similarity, identification, and self-referencing</article-title>. <source>J Health Commun</source> (<year>2016</year>) <volume>21</volume>(<issue>8</issue>):<fpage>908</fpage>&#x02013;<lpage>18</lpage>.<pub-id pub-id-type="doi">10.1080/10810730.2016.1177147</pub-id><pub-id pub-id-type="pmid">27411000</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graaf</surname><given-names>AD</given-names></name><name><surname>Sanders</surname><given-names>J</given-names></name><name><surname>Hoeken</surname><given-names>H</given-names></name></person-group>
<article-title>Characteristics of narrative interventions and health effects: a review of the content, form, and context of narratives in health-related narrative persuasion research</article-title>. <source>Rev Commun Res</source> (<year>2016</year>) <volume>4</volume>:<fpage>88</fpage>&#x02013;<lpage>131</lpage>.<pub-id pub-id-type="doi">10.12840/issn.2255-4165.2016.04.01.011</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tukachinsky</surname><given-names>R</given-names></name><name><surname>Tokunaga</surname><given-names>R</given-names></name></person-group>
<article-title>The effects of engagement with entertainment</article-title>. <source>Ann Int Commun Assoc</source> (<year>2013</year>) <volume>37</volume>:<fpage>287</fpage>&#x02013;<lpage>322</lpage>.<pub-id pub-id-type="doi">10.1080/23808985.2013.11679153</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="webpage"><collab>Centers for Disease Control and Prevention (CDC)</collab>. <source>Why HPV Vaccine Is Important to My Family: The Story of a Cervical Cancer Survivor</source>. (<year>2017</year>) [cited 2018 April 2]. Available from: <uri xlink:type="simple" xlink:href="https://www2c.cdc.gov/podcasts/media/pdf/CDC_JackiesStory_POD.pdf">https://www2c.cdc.gov/podcasts/media/pdf/CDC_JackiesStory_POD.pdf</uri></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nan</surname><given-names>X</given-names></name><name><surname>Madden</surname><given-names>K</given-names></name></person-group>. <article-title>HPV vaccine information in the blogosphere: how positive and negative blogs influence vaccine-related risk perceptions, attitudes, and behavioral intentions</article-title>. <source>Health Commun</source> (<year>2012</year>) <volume>27</volume>(<issue>8</issue>):<fpage>829</fpage>&#x02013;<lpage>36</lpage>.<pub-id pub-id-type="doi">10.1080/10410236.2012.661348</pub-id><pub-id pub-id-type="pmid">22452582</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abhyankar</surname><given-names>P</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>D</given-names></name><name><surname>Lawton</surname><given-names>R</given-names></name></person-group>. <article-title>The role of message framing in promoting MMR vaccination: evidence of a loss-frame advantage</article-title>. <source>Psychol Health Med</source> (<year>2008</year>) <volume>13</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="doi">10.1080/13548500701235732</pub-id><pub-id pub-id-type="pmid">18066916</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faul</surname><given-names>F</given-names></name><name><surname>Erdfelder</surname><given-names>E</given-names></name><name><surname>Buchner</surname><given-names>A</given-names></name><name><surname>Lang</surname><given-names>A</given-names></name></person-group>. <article-title>Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses</article-title>. <source>Behav Res Methods</source> (<year>2009</year>) <volume>41</volume>(<issue>4</issue>):<fpage>1149</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="doi">10.3758/BRM.41.4.1149</pub-id><pub-id pub-id-type="pmid">19897823</pub-id></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faul</surname><given-names>F</given-names></name><name><surname>Erdfelder</surname><given-names>E</given-names></name><name><surname>Lang</surname><given-names>A</given-names></name><name><surname>Buchner</surname><given-names>A</given-names></name></person-group>. <article-title>G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences</article-title>. <source>Behav Res Methods</source> (<year>2007</year>) <volume>39</volume>(<issue>2</issue>):<fpage>175</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.3758/BF03193146</pub-id><pub-id pub-id-type="pmid">17695343</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Senn</surname><given-names>S</given-names></name></person-group>. <article-title>Testing for baseline balance in clinical trials</article-title>. <source>Stat Med</source> (<year>1994</year>) <volume>13</volume>(<issue>17</issue>):<fpage>1715</fpage>&#x02013;<lpage>26</lpage>.<pub-id pub-id-type="doi">10.1002/sim.4780131703</pub-id><pub-id pub-id-type="pmid">7997705</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Assmann</surname><given-names>SF</given-names></name><name><surname>Pocock</surname><given-names>SJ</given-names></name><name><surname>Enos</surname><given-names>LE</given-names></name><name><surname>Kasten</surname><given-names>LE</given-names></name></person-group>. <article-title>Subgroup analysis and other (mis)uses of baseline data in clinical trials</article-title>. <source>Lancet</source> (<year>2000</year>) <volume>355</volume>(<issue>9209</issue>):<fpage>1064</fpage>.<pub-id pub-id-type="doi">10.1016/S0140-6736(00)02039-0</pub-id><pub-id pub-id-type="pmid">10744093</pub-id></mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moher</surname><given-names>D</given-names></name><name><surname>Hopewell</surname><given-names>S</given-names></name><name><surname>Schulz</surname><given-names>KF</given-names></name><name><surname>Montori</surname><given-names>V</given-names></name><name><surname>G&#x000f8;tzsche</surname><given-names>PC</given-names></name><name><surname>Devereaux</surname><given-names>PJ</given-names></name><etal/></person-group>
<article-title>CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials</article-title>. <source>BMJ</source> (<year>2010</year>) <volume>340</volume>:<fpage>c869</fpage><pub-id pub-id-type="doi">10.1136/bmj.c869</pub-id><pub-id pub-id-type="pmid">20332511</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Torgerson</surname><given-names>DJ</given-names></name><name><surname>Torgerson</surname><given-names>CJ</given-names></name></person-group>
<source>Designing Randomised Trials in Health, Education and the Social Sciences: An Introduction</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Palgrave Macmillan</publisher-name> (<year>2008</year>). p. <fpage>138</fpage>&#x02013;<lpage>43</lpage>.</mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Torgerson</surname><given-names>DJ</given-names></name><name><surname>Torgerson</surname><given-names>CJ</given-names></name></person-group>
<source>Designing Randomised Trials in Health, Education and the Social Sciences: An Introduction</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Palgrave Macmillan</publisher-name> (<year>2008</year>). p. <fpage>9</fpage>&#x02013;<lpage>16</lpage>.</mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moyer-Guse</surname><given-names>E</given-names></name><name><surname>Nabi</surname><given-names>R</given-names></name></person-group>
<article-title>Explaining the effects of narrative in an entertainment television program: overcoming resistance to persuasion</article-title>. <source>Hum Commun Res</source> (<year>2010</year>) <volume>36</volume>(<issue>1</issue>):<fpage>26</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="doi">10.1111/j.1468-2958.2009.01367.x</pub-id></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheeran</surname><given-names>P</given-names></name></person-group>
<article-title>Intention&#x02014;behavior relations: a conceptual and empirical review</article-title>. <source>Eur Rev Soc Psychol</source> (<year>2002</year>) <volume>12</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>36</lpage>.<pub-id pub-id-type="doi">10.1080/14792772143000003</pub-id></mixed-citation></ref></ref-list></back></article>